Inmune Bio, INC Schedule 13G passive stakes

Highbridge Capital Management, LLC reported a 5.2% beneficial ownership stake in Inmune Bio, Inc., primarily through warrants.

CVI Investments, Inc. and Heights Capital Management, Inc. disclose a 4.9% passive beneficial ownership in INmune Bio Inc. common stock, primarily through warrants.

Multiple investment entities and individuals, including Praetorian Capital and Mongolia Growth Group, have disclosed their beneficial ownership in Inmune Bio, Inc., totaling up to 3.4% of outstanding shares.

CVI Investments, Inc. and its investment manager, Heights Capital Management, Inc., have disclosed a combined beneficial ownership of 5.5% of INmune Bio Inc.'s common stock.

Praetorian Capital Fund LLC, Mongolia (Barbados) Corp., and related entities, including Harris Kupperman, have disclosed a combined beneficial ownership of 7.2% in Inmune Bio, Inc. as of March 31, 2025.

Harris Kupperman, through various affiliated entities including Praetorian Capital and Mongolia Growth Group, has disclosed a combined passive beneficial ownership of 5.5% in INmune Bio Inc., totaling 1,238,963 shares.